Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ICODEXTRIN vs IDARUCIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ICODEXTRIN vs IDARUCIZUMAB: Safety Overview

Metric ICODEXTRIN IDARUCIZUMAB
Total FAERS Reports 253 1,562
Deaths Reported 70 1,014
Death Rate 27.7% 64.9%
Hospitalizations 147 570
Average Patient Age 63.1 yrs 77.6 yrs
% Female Patients 42.7% 42.7%
FDA Approval Date Dec 20, 2002 N/A
Manufacturer N/A Boehringer Ingelheim Pharmaceuticals,...
Route N/A INTRAVENOUS
Marketing Status Prescription Prescription